Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Lycke

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Vaccine|September 20, 2005
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionMarina De Filette, Anna Ramne, Ashley Birkett, et al.
Vaccine|July 4, 2006
Improved design and intranasal delivery of an M2e-based human influenza A vaccineMarina De Filette, Walter Fiers, Wouter Martens, et al.
Vaccine|February 5, 2008
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccineDubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön, et al.
Nature Immunology|March 20, 2019
Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietinLiang Ye, Daniel Schnepf, Jan Becker, et al.
Mucosal Immunology|March 9, 2022
Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversityAjibola Omokanye, Li Ching Ong, Cristina Lebrero-Fernandez, et al.
Nature Communications|June 5, 2019
Activated Peyer's patch B cells sample antigen directly from M cells in the subepithelial domeRathan Joy Komban, Anneli Strömberg, Adi Biram, et al.
Vaccines|July 2, 2021
Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera VaccinesAqel Albutti, Stephanie Longet, Craig P McEntee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Antibiotic-killed Staphylococcus aureus induces destructive arthritis in miceAbukar Ali, Xuefeng Zhu, Jakub Kwiecinski, et al.
Frontiers in Immunology|October 2, 2018
Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus InfectionsValentina Bernasconi, Beatrice Bernocchi, Liang Ye, et al.
Mucosal Immunology|April 14, 2022
ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infectionMohammad Arabpour, Cristina Lebrero-Fernandez, Karin Schön, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Vaccine|September 20, 2005
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionMarina De Filette, Anna Ramne, Ashley Birkett, et al.
Vaccine|July 4, 2006
Improved design and intranasal delivery of an M2e-based human influenza A vaccineMarina De Filette, Walter Fiers, Wouter Martens, et al.
Vaccine|February 5, 2008
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccineDubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön, et al.
Nature Immunology|March 20, 2019
Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietinLiang Ye, Daniel Schnepf, Jan Becker, et al.
Mucosal Immunology|March 9, 2022
Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversityAjibola Omokanye, Li Ching Ong, Cristina Lebrero-Fernandez, et al.
Nature Communications|June 5, 2019
Activated Peyer's patch B cells sample antigen directly from M cells in the subepithelial domeRathan Joy Komban, Anneli Strömberg, Adi Biram, et al.
Vaccines|July 2, 2021
Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera VaccinesAqel Albutti, Stephanie Longet, Craig P McEntee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Antibiotic-killed Staphylococcus aureus induces destructive arthritis in miceAbukar Ali, Xuefeng Zhu, Jakub Kwiecinski, et al.
Frontiers in Immunology|October 2, 2018
Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus InfectionsValentina Bernasconi, Beatrice Bernocchi, Liang Ye, et al.
Mucosal Immunology|April 14, 2022
ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infectionMohammad Arabpour, Cristina Lebrero-Fernandez, Karin Schön, et al.
Pageof 5